Endocrine disruptor compounds-a cause of impaired immune tolerance driving inflammatory disorders of pregnancy? by Schjenken, J.E. et al.
Frontiers in Endocrinology | www.frontiersi
Edited by:
Carlo Alviggi,









†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Reproduction,
a section of the journal
Frontiers in Endocrinology
Received: 17 September 2020
Accepted: 04 January 2021
Published: 12 April 2021
Citation:
Schjenken JE, Green ES, Overduin TS,









published: 12 April 2021
doi: 10.3389/fendo.2021.607539Endocrine Disruptor Compounds—
A Cause of Impaired Immune
Tolerance Driving Inflammatory
Disorders of Pregnancy?
John E. Schjenken1,2†, Ella S. Green1†, Tenuis S. Overduin1, Chui Yan Mah1, Darryl L. Russell1
and Sarah A. Robertson1*
1 Adelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia, 2 Priority
Research Centre for Reproductive Science, Discipline of Biological Sciences, The Hunter Medical Research Institute, New
Lambton Heights and the University of Newcastle, Newcastle, NSW, Australia
Endocrine disrupting compounds (EDCs) are prevalent and ubiquitous in our environment
and have substantial potential to compromise human and animal health. Amongst the
chronic health conditions associated with EDC exposure, dysregulation of reproductive
function in both females and males is prominent. Human epidemiological studies
demonstrate links between EDC exposure and infertility, as well as gestational
disorders including miscarriage, fetal growth restriction, preeclampsia, and preterm
birth. Animal experiments show EDCs administered during gestation, or to either parent
prior to conception, can interfere with gamete quality, embryo implantation, and placental
and fetal development, with consequences for offspring viability and health. It has been
presumed that EDCs operate principally through disrupting hormone-regulated events in
reproduction and fetal development, but EDC effects on maternal immune receptivity to
pregnancy are also implicated. EDCs can modulate both the innate and adaptive arms of
the immune system, to alter inflammatory responses, and interfere with generation of
regulatory T (Treg) cells that are critical for pregnancy tolerance. Effects of EDCs on
immune cells are complex and likely exerted by both steroid hormone-dependent and
hormone-independent pathways. Thus, to better understand how EDCs impact
reproduction and pregnancy, it is imperative to consider how immune-mediated
mechanisms are affected by EDCs. This review will describe evidence that several
EDCs modify elements of the immune response relevant to pregnancy, and will discuss
the potential for EDCs to disrupt immune tolerance required for robust placentation and
optimal fetal development.
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Endocrine disrupting compounds (EDCs) are defined by their
potential to alter endocrine function through mimicking or
blocking the actions of endogenous hormones (1, 2). Exposure
to EDCs is considered a contributing factor in the increasing
prevalence of common metabolic, neurological and inflammatory
diseases. Male and female reproductive disorders, and a myriad of
conditions including obesity, diabetes, non-alcoholic fatty liver
disease, neurodevelopmental disorders, allergy, asthma,
autoimmunity, and cancer, are all associated with EDC exposure
(1). Alarmingly, the estimated human disease cost of EDCs in
2016 was 2.33% of GDP ($340 billion USD) in the USA and 1% of
GDP ($217 billion USD) in Europe (3). Recent reports
commissioned by the World Health Organization recommend
greater investment in research to better understand the health
impact of EDCs. Identified research goals include the development
of comprehensive testing methods to detect EDCs, improved
reporting mechanisms for chemical composition of products,
and the need for more cross-disciplinary research to fully
understand the impact on public and global health of EDCs
contacted in everyday life (1).
EDCs are structurally and functionally diverse chemicals that
can be natural or synthetic in origin (1). Natural forms include
phytoestrogens found in widely-consumed food and animal
products. These are likely less harmful than synthetic EDCs
since they have generally low affinity for estrogen receptors (ER)
(4), and exhibit low stability compared to many synthetic
compounds that are engineered to be stable. However, given
the high levels present in some foods, including infant formula,
and the fact that the abundant phytoestrogen genistein binds
ERb with relatively high affinity, the potential health impacts of
phytoestrogens need to be considered (4, 5).
Synthetic EDCs are far more diverse with several hundred
identified and classified as persistent (exhibiting bioaccumulation)
or non-persistent in the environment (2, 5). These compounds are
present in many commonly used household and industrial
products. They include chemicals used as solvents or lubricants,
plasticizers, pesticides, fungicides, and pharmaceutical agents, that
are present in plastics, detergents, household chemicals and
building products, fire retardants, food, medicines, personal care
products, perfume, and cosmetics (5).
EDCs interfere with the synthesis, biological actions, and
metabolism of endocrine hormones, and disrupt hormone-
regulated homeostatic processes in many tissues and physiological
systems (2, 5). Through competitive interactions with hormone
receptors, EDCs can act as agonists or antagonists and have a
multitude of effects that range from enhancement, dampening, or
blocking the action of endogenous hormones (2). Depending on the
nature of the interaction, EDCs often exert non-monotonic dose
responses characterized by low-dose effects, rather than linear dose
responses like most other bioactive agents (6, 7). EDCs can also
modulate synthesis of hormones and their respective receptors (2).
Through these actions, they can interfere with physiological events
and tissue homeostasis over the entire life cycle (2, 8–10).
Depending on variables such as the duration, type, and dose of
exposure, EDCs can exert transient or permanent impacts, to elevateFrontiers in Endocrinology | www.frontiersin.org 2long-term risk of chronic metabolic, neurological and immune
diseases that may only become evident in later life (2, 9).
The events of reproduction, pregnancy, and fetal development
are highly sensitive to EDCs because they involve a greater degree
of tissue remodeling and hormone-dependence than other
physiological processes. EDCs exert negative impacts on fertility
and reproductive outcome, affecting gamete, embryo, and fetal
development (2, 8, 11–13), with consequences that can cause fetal
loss or attenuate offspring phenotype to impact lifetime health (2,
9, 14–19). The specific mechanisms by which different EDCs exert
adverse developmental effects are not yet clear, and are likely to be
complex and diverse. A large body of research has been generated
in recent years to describe actions in different male and female
reproductive tissue compartments. These actions are largely
attributed to disruption of the hormone signaling that regulates
most aspects of male and female reproductive physiology (2, 5).
In addition, EDCs are now understood to affect immune system
development and function (20, 21), modulating many aspects of
inflammatory and immune responses involving both the innate and
adaptive immune compartments (22–29) (Table 1). Most
reproductive processes are intimately dependent on a functional
and appropriately balanced immune response (32, 33). Placental
development and fetal growth are particularly dependent on
adequate support from the maternal immune system (34), and a
deficit in maternal immune cells and mediators that confer fetal
tolerance is a central causeofpoorgestationaloutcomesand impaired
fetal development. An aberrant maternal immune response, that is
insufficient in strength or skewed towards inflammation, can
manifest as infertility, pregnancy loss, or a poor gestational
outcome (32, 33, 35). Most often, these outcomes stem from failure
of the maternal immune response to support embryo implantation
and allow robust placental development (35–37).
These considerations raise the question of whether the
adverse effects of EDCs on reproduction and pregnancy are at
least partly due to mechanisms mediated by immune cells. Given
the central role of the immune response in pregnancy, and the
ubiquitous exposure of humans to environmental EDCs, it seems
likely that EDC-induced immune disorders are a factor in the
increasing incidence of fertility and gestational disorders.
This review will summarise evidence that common EDCs have
capacity to interfere with pregnancy and fetal development through
modifying maternal immune cells and mediators. Wemake the case
that, given its critical importance to pregnancy outcome, and its
sensitivity to perturbation by EDCs in other settings, the immune
response warrants investigation as a mechanism by which EDCs
affect reproductive success. Ultimately, devising strategies to protect
humans and animals from the adverse reproductive effects of EDCs
will require greater understanding of the how the immune system–
EDC interaction contributes.ENDOCRINE DISRUPTING COMPOUNDS
AND REPRODUCTION
EDCs are well-documented to interfere with male and female
reproductive hormone function, through genomic and non-
genomic mechanisms that exert a wide range of endocrineApril 2021 | Volume 12 | Article 607539
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binding of hormones to their corresponding receptors, notably
including estrogen receptor and androgen receptor to cause
either agonistic or antagonistic effects. The net consequence is
interference with physiologically normal signal transduction
pathways, eliciting downstream changes to target gene
expression and cellular function (38). Different EDCs exert a
variety of effects on hormone signaling depending on the timing
of exposure and the amount of EDC administered (2, 5).
Dysregulated hormone synthesis and signaling in reproductive
tissues, and systemically in the hypothalamic-pituitary axis,
thyroid, and other tissues influencing reproductive function,
converge to have substantial consequences for sexual maturation
and fertility (39–41). Emerging evidence indicates that sensitivity
to EDCs is modulated by age and a range of environmental,
lifestyle, and genetic factors that can exacerbate the impact of
EDCs on reproductive health (3, 42, 43). These factors contributeFrontiers in Endocrinology | www.frontiersin.org 3to the difficulty in comparing studies and considerable
discrepancies between study outcomes (3, 44).
Large clinical studies show correlations between EDC
exposure and fertility disorders in women. Most notably,
occupational exposure to EDCs, or consumption of EDC-laden
foods, are associated with increased risk of infertility, time-to-
pregnancy, and early pregnancy loss (14, 45). These effects may
reflect early life and life course accumulated exposures. In
particular, prenatal effects of EDCs are linked with later life
incidence of reproductive conditions including polycystic
ovarian syndrome, endometriosis, uterine fibroids, and
reproductive cancers (9). In an IVF setting, women exposed to
certain pesticides appear more likely to exhibit defects in oocyte
maturation and developmental competence, leading to impaired
fertility, embryonic defects, and poor IVF outcomes (41, 45).
Research in rodent models provides insight on how EDCs impact
reproductive endocrinology (2, 40, 46). These manifest most
obviously as altered timing of sexual maturation, impaired gamete
development, and reduced fecundity (39, 46). For example
administration to rodents or large animals of plasticizers such as
phthalates and bisphenol A, (BPA), or pesticides including
vinclozolin and glyphosate, all cause reduced ovarian weight,
impaired follicle growth and oocyte viability, and reduced synthesis
of ovarian sex steroid hormones (46–48). For detailed information on
the specific impacts of EDCs on female reproductive physiology, the
reader is directed to the following reviews (2, 5, 9, 40, 46, 49).
EDCs also exert considerable effects on male reproduction and
gamete developmental competence. Direct or gestational exposure
of male rats and mice to any of several EDCs leads to reduced
reproductive capacity, characterized by decreased gonad weight,
testosterone levels, and gamete quality, as well as increased
likelihood of reproductive conditions including testicular cancer,
cryptorchidism, and hypospadias (39, 40, 50). In vitro studies show
in cattle that exposure to low doses of the herbicide atrazine reduces
sperm viability and impairs capacity to undergo acrosome reaction
in response to calcium signals (51). In men, epidemiological
evidence shows a clear negative association between EDCs and
male reproductive parameters, in association with reduced sperm
concentration, motility, viability, DNA integrity, and altered sperm
methylation patterns (40, 50, 52, 53). Various EDCs are also readily
detectable in seminal plasma (54), and the seminal vesicles, which
are the major source of seminal plasma, are an important target of
EDCs including diethylstilbestrol that targets estrogen receptor-a
(55). These changes are likely to compromise fertility, and alter
reproductive outcomes beyond the fertilising capacity of sperm. In
men utilising IVF clinics, exposure to phthalates was associated with
differential methylation of specific DNA sequences in sperm, and
was inversely associated with blastocyst quality (53). A wide range of
specific effects of EDCs on male reproduction are reported, and
these are reviewed in detail elsewhere (2, 5, 9, 39, 40).ENDOCRINE DISRUPTING COMPOUNDS
AND PREGNANCY
Fetal and placental development are highly hormone-dependent
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high risk of EDC exposure, especially through everyday exposure
to personal care products and household chemicals, and the events
of pregnancy would reasonably heighten the health risks of EDC
exposure in women (56). There is compelling evidence implicating
EDC exposures as a risk factor in a range of pregnancy disorders
(59–63). Several clinical and epidemiological studies link EDCs,
notably pesticides and plasticizers, in common pregnancy
complications that together affect around 20% of women,
including recurrent miscarriage, fetal growth restriction,
preeclampsia and related hypertensive disorders, and preterm
birth (13, 56, 61, 64, 65). Many studies consistently show a wide
array of EDCs are detectable in the urine, cord blood, plasma,
amniotic fluid and breast milk of the vast majority of pregnant
women (66–68). Patterns of exposure depend on geographic,
socioeconomic, occupational and lifestyle factors, and fluctuate
over the course of pregnancy, to occur in infinitely variable
combinations (known as the ‘exposome’) that might have
stronger relationships to adverse outcomes than any individual
chemical exposure (69, 70). Nevertheless, while causal
relationships are difficult to prove in humans, extensive studies
show strong evidence of correlations between adverse clinical
outcomes and serum or urinary levels of bisphenol A (BPA),
phthalate metabolites, organophosphate pesticides, and other
EDCs (61, 71–73).
EDCs may operate through pre-pregnancy exposures that
affect organs systems critical for pregnancy health, through
gestational exposures that interfere with hormone control of
fetal and placental development and function, or other via
systemic adaptations required to sustain pregnancy (63). There
is clear evidence that pregnant women with existing health
disparities, associated with low socioeconomic status, or certain
racial groups such as non-white women in the US where levels of
chemical toxicants are often higher, exhibit a disproportionate
health burden associate with EDC exposures (3, 44).
The placenta is implicated as an important target for EDC
actions. As a rapidly developing, dynamic organ the placenta is
highly responsive to hormone regulation during its morphogenesis,
and expresses a wide array of hormone receptors that control
placental supply of nutrients to the growing fetus (57, 58). The
placenta adapts to fetal and environmental cues to reconcile fetal
demand for growth with nutrient availability, and disruption of
hormone signaling interferes with this adaptive capability to disturb
fetal growth and developmental programming (57).
Animal models document a range of potential mechanisms by
which EDCs disrupt placental and fetal development. Some EDCs,
notably including BPA and triclosan, accumulate directly in
placental tissues, where they modulate placental hormone
synthesis and metabolism (74, 75). In vitro experiments show
that a range of EDCs can exert direct effect in trophoblasts
including regulation of signaling pathways to cause genetic and
epigenetic changes that impact cell survival and invasive capability
(75). It seems likely that effects of EDCs are prominent in early
pregnancy during placental morphogenesis, when the extent of
invasion into maternal tissues, and interaction with the maternal
vasculature, is rate-limiting for later gestation placental transportFrontiers in Endocrinology | www.frontiersin.org 4function (58). However because EDC effects in placental cells have
not been well investigated to date, it is not yet possible to discern
the contribution of direct effects in trophoblasts, versus
mechanisms that involve the maternal compartment (58).ENDOCRINE DISRUPTING COMPOUNDS
AND OFFSPRING HEALTH
The effects of EDCs on the developing fetus have a lasting impact
on offspring phenotype and susceptibility to later life health and
disease (9, 76). The developmental defects caused by maternal
EDC administration in pregnancy can have life-long and even
transgenerational consequences (77). Maternal EDC exposures
likely impart changes to offspring health and behaviour through
direct effects in the placenta and fetus, as well as indirectly
through maternal physiological adaptations required to
support pregnancy.
Animal studies show EDCs including pesticides, phthalates
and BPA act to decrease fertility, alter anogenital distance, cause
early puberty, and disrupt testis/ovarian function in both male
and female offspring (40). These exposures not only disrupt
offspring reproductive capacity, but also alter aspects of
development affecting brain and endocrine function (15, 16,
78). In humans there is compelling evidence that gestational
exposure to a variety of EDCs during fetal life leads to decreased
infant birth weight, reduced anogenital distance in male
neonates, increased incidence of childhood obesity, and
alterations to neurodevelopment and cognitive function,
leading to reduced IQ and behavioral problems (9).
Concerningly, there is emerging evidence that EDCs can exert
transgenerational effects, such that not only the immediate
offspring, but also future generations may be impacted after
maternal contact in pregnancy (9, 40). This may be mediated
through epigenetic modifications to DNAmethylation profiles in
fetal gametes, caused by inappropriate timing or inhibition of
activation signals during gamete development, or through DNA
adduction induced by EDCs or their metabolites (40, 79).
The impact of paternal exposures and their mechanisms of
action are less well defined, but emerging evidence points to
effects on offspring phenotype mediated by altered epigenetic
properties of sperm (80). Furthermore, EDCs present in seminal
plasma (54), or altered seminal plasma composition resulting
from EDC-attenuated ERa signaling (55), have potential to
transmit effects of paternal exposures to offspring. This could
occur by impaired capacity of seminal plasma to support sperm
integrity, or by attenuating seminal plasma signals that modulate
female reproductive tract gene expression and receptivity for
pregnancy (81, 82). In mice, it has been reported that paternal
contact with BPA prior to conception impairs offspring spatial
memory (19), and alters social behaviour with increased anxiety
in male offspring (83). These can begin very early in the life
course – male fetuses exposed in utero to the fungicide
vinclozolin or pesticide dichlorodiphenyltrichloroethane
(DDT) exhibit later epigenetic changes in sperm that can beApril 2021 | Volume 12 | Article 607539
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synthetic estrogen 17a-ethinylestradiol leads to an altered sperm
and testicular transcript content, causing lymphodema in
offspring (85). In human, recent evidence from a large-scale
epidemiological study demonstrates a link between birth defects
and fathers’ occupational exposure to EDCs (17).VIVIPAROUS REPRODUCTION AND THE
IMMUNE RESPONSE
The embryo and the gestational tissues formed after implantation
express antigens foreign to the mother, including transplantation
antigens encoded by major histocompatibility complex (MHC)
genes (33, 86). Both the innate and adaptive compartments are
involved in the maternal immune adaptions required to avert
effector immune responses to conceptus antigens (86, 87).
Contrary to common assumptions, pregnancy requires a state of
adaptive immune tolerance that depends on maternal lymphocytes
being actively primed to recognise conceptus antigens (35, 86).
Priming of the adaptive immune compartment must commence
prior to implantation in order to initiate the necessary events of
implantation, placental development and fetal growth, and
ultimately to orchestrate on-time parturition and birth (35, 86).
Immune Mechanisms Essential for
Implantation and Placental Development
Tightly controlled maternal immune regulation is important over
the course of pregnancy, but the most critical period is the peri-
conception phase spanning fertilization to embryo implantation
(35). A series of dynamic changes in the uterine immune response
determine whether or not embryo implantation can occur (88),
and are instrumental in setting the trajectory of fetal development
and shaping the offspring phenotype (35, 80, 89). Immune
adaptation commences with sex hormone-induced changes in
the ovulatory cycle followed by an inflammation-like response
to seminal fluid components at coitus (90). Estrogen and seminal
fluid together induce an influx of neutrophils, macrophages and
dendritic cells (DCs), into the mucosal surface of the cervix and
uterus (91–94). This is followed by transition to an anti-
inflammatory and pro-tolerogenic immune environment in
order to acquire embryo receptivity (34, 35, 86). Implantation
only occurs if immune cells in the uterine endometrium exhibit a
favourable, permissive response. In particular, expansion and
recruitment of specialized immune cells known as regulatory T
cells (Treg cells) must occur (95–98). Treg cells interact with
dendritic cells and macrophages to promote decidualisation of
uterine stromal cells, suppress inflammation, and inhibit effector
immunity towards fetal antigens.
After implantation, an array of soluble mediators including
cytokines, chemokines, steroid hormones, and prostaglandins
released from placental trophoblasts are important for sustaining
the developing fetal-placental unit (32). As well as Treg cells,
abundant populations of uterine natural killer (uNK) cells act to
mediate structural changes in the decidual vasculature that
support placental invasion and development (99–101).Frontiers in Endocrinology | www.frontiersin.org 5Macrophages, DCs, and Treg cells each interact with uNK cells
to facilitate the uterine vascular changes, while continuing to
suppress inflammation and prevent immune effector cell
activation (35, 100, 101) (Figure 1).ENDOCRINE DISRUPTING COMPOUNDS
AND THE IMMUNE RESPONSE
TO PREGNANCY
Maternal EDC exposure is an identified risk factor in
unexplained infertility and pregnancy complications, including
preeclampsia, intra-uterine growth restriction, recurrent
miscarriage, and spontaneous preterm birth (13, 61, 64, 65).
Interference in hormone synthesis and signaling is implicated in
the mechanisms by which EDCs contribute to pregnancy
disorders (9), and there is a strong biological rationale to
implicate inflammation, oxidative stress, and immune cells as
local mediators of the pathophysiological changes induces by
hormone dysregulation (59). That immune and inflammatory
mechanisms are central to infertility and pregnancy disorders
supports the prospect that EDCs act, at least in part, by driving
an inappropriate maternal immune response (20, 21).
There is some evidence that EDCs are especially problematic
in the peri-conception phase of pregnancy, when the maternal
immune response is first established and the critical events of
implantation and early placentation occur. Elevated phthalate
metabolites in urine were shown to correlate with altered
progression of embryo implantation, as indicated by a slower
or faster rise in human chorionic gonadotrophin, with different
metabolites appearing to be protective or adverse in their effects
(102). Whether immune mechanisms are involved is not known,
but seems biologically plausible. Others have shown that first
trimester maternal peripheral blood cytokine levels correlate
with the presence of several EDCs in urine, with a notable
association between phthalates and pro-inflammatory
interleukin (IL)-8 and interferon (IFN) (70). In another study,
clear associations between polybrominated diphenyl ethers
(PDBEs) and pro-inflammatory cytokines IL-6 and tumor
necrosis factor (TNF), as well as between per- and poly-
fluorochemicals (PFAS) and IL-6, were found in maternal
peripheral blood in the second trimester (103). Similar
associations between EDCs and pro-inflammatory cytokines
were seen at term, in infant cord blood (70). These
observations are consistent with EDCs acting to impair
resolution of the inflammatory response in early pregnancy
and compromise tolerance as pregnancy progresses, but
additional studies would be required to prove this.
Only a small number of mechanistic studies have specifically
explored the impact of EDCs on maternal or fetal immune
parameters in pregnancy, but several point to a pro-inflammatory
pathology that affects the vascular adaptations required for robust
placental development. In mice, short-term oral BPA exposure in
early pregnancy was shown to cause impaired spiral artery
remodeling and intra-uterine growth restriction (11). Although
the number of uNK and mast cells was not changed, this studyApril 2021 | Volume 12 | Article 607539
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other immune cell populations. Another study reported reduced
trophoblast invasion and impairment of uterine vascular
remodeling after low dose BPA administration in mice, along
with preeclampsia-like features of maternal hypertension and
elevated angiogenesis biomarkers and glomerular atrophy (104).
Also consistent with an inflammatory mechanism, administration
of polychlorinated biphenol (PCB) to mink resulted in uterine
vascular changes and placental lesions, with degeneration of
endothelial and trophoblast cells, particularly in the placental
labyrinth zone (105). Low dose 17a-ethinylestradiol, used in oral
contraceptive pills and prevalent in water supplies, caused impaired
spiral artery remodeling, altered placental development, and fetal
growth restriction (106). In non-pregnant mice, uterine expression
of heat shock proteins (HSPs) that play important roles in antigen
presentation and DC function are elevated in response to low dose
BPA (107), but the impact of elevated HSPs on pregnancy is
not clear.
Studies in other reproductive tissues are consistent with
possible pro-inflammatory and immune-mediated effects ofFrontiers in Endocrinology | www.frontiersin.org 6EDCs (108). In the mammary gland, BPA exposure in utero
causes long term changes in expression of both pro- and anti-
inflammatory cytokines, and this is postulated to be a potential
mechanism for programming breast cancer risk (109).
As well as influencing the maternal immune compartment,
EDCs likely elicit direct effects on immune cells in the placenta
and fetus. The presence of EDCs in amniotic fluid and cord
blood shows that many chemicals cross the placenta to access
fetal tissues (58, 75). A wide range of EDCs including pesticides,
plasticizers, fire retardants, and components of personal care
products can be detected in the placenta (75). Compelling
evidence of EDC effects on the developing fetal immune
response is emerging (110, 111). In particular, phthalates and
phenols are implicated as a factor in fetal programming of
asthma and allergic airways disease, while heavy metals and
air-borne particulates also contribute (21, 112). A wide range of
immunomodulatory effects of EDCs on human immune cell
development are reported, through mechanisms operating at the
cellular, molecular, and epigenetic levels to alter innate and
adaptive immune function in offspring (110).FIGURE 1 | Immune cells including macrophages, natural killer (NK) cells, regulatory T cells (Treg cells), neutrophils and tolerogenic dendritic cells (tDC) residing in
the uterine decidua each contribute in a network of cellular interactions to facilitate embryo (blastocyst) implantation and trophoblast outgrowth, required for
progression to healthy pregnancy. The decidual immune cells exert a range of regulatory effects on the local microenvironment that each contribute to the success of
implantation, ensuring robust placental development that in turn supports healthy fetal growth and development in later gestation. The immune cells together act to
mediate immune tolerance, suppress inflammation, inhibit effector immunity mediated by T helper type 1 (Th1) cells, promote uterine blood vessel remodeling, and
facilitate transformation of uterine stromal cells in the decidual response. Ovarian sex steroid hormones estrogen (E2) and progesterone (P4) act to regulate immune
cell populations through direct effects in immune cells, and indirect effects mediated by non-immune cell synthesis of immune-regulatory factors.April 2021 | Volume 12 | Article 607539
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OF IMMUNE CELLS
A clear mechanism for EDCs exerting significant influence on
the maternal immune environment exists, as endocrine signaling
in immune cells is an important aspect of normal immune
regulation (113). Steroid hormones exert both direct and
indirect influence on immune cells, the former through
ligation of classical steroid hormone receptors for estrogen,
androgens, and progesterone, to regulate a wide range of target
genes. In addition, steroid hormones have rapid non-genomic
effects in immune cells via binding to non-classical receptors on
the cell membrane or in the cytoplasm (114). As well, steroid
hormones control expression of a vast array of cytokines and
chemokines in non-immune cell lineages in hormone-responsive
reproductive tissues, to exert indirect effects on resident immune
cell populations through this route (115).
It is well known that female sex steroid hormones exert potent
regulatory effects on immune cells systemically and locally within
the female reproductive tract over the course of the menstrual
cycle and during pregnancy. In particular, estrogen and
progesterone play important roles in the induction of maternal
immune tolerance, both through direct signaling in immune cells
and indirectly through actions on epithelial and stromal cells in
the female reproductive tract (116, 117). Over the course of the
estrous and menstrual cycle and after conception, estrogen and
progesterone are key factors in driving expansion of Treg cells in
readiness to accommodate embryo implantation (118–120).Frontiers in Endocrinology | www.frontiersin.org 7Given this direct and indirect regulation by hormones, immune
cells are highly susceptible to the effects of EDCs. EDCs broadly
affect various immunological processes, including cellular and
humoral responses, survival, differentiation and phenotypic
maturation, as well as secretion of cytokines and other immune
signaling mediators (22). Emerging evidence demonstrates
substantial potential for EDCs to interfere with the endocrine
signaling required for maternal immune adaptation to pregnancy
(Figure 2). Below, we summarise the current evidence for EDC
action on the innate and adaptive components of the immune
response relevant to pregnancy, with a focus on immune cell types
affected by EDCs and implicated in reproductive success. The
argument that EDCs may act in pregnancy through influencing
the maternal immune response is supported by studies of EDC
effects on immune cells in other tissue settings and disease contexts.
Macrophages
Macrophages contribute to embryo implantation, placental
development, and timing of birth (35, 121, 122). In the
maternal compartment, immune-regulatory macrophages
constrain inflammation, influence the adaptive immune
response, and modulate uterine vascular function (123). EDC
disruption of their functional phenotypes is likely to adversely
impact placental morphogenesis, pregnancy progression and
fetal development. In the placenta, a large population of fetus-
derived macrophages known as ‘Hofbauer cells’ exert direct
effects on placental development and transport function. These
cells can respond to proinflammatory stimuli and contribute toFIGURE 2 | Summary of EDC effects on immune cell subsets and potential implications for maternal immune adaptation to pregnancy. Various EDCs affect the
differentiation, phenotype and function of specific immune cell subsets, each of which play important roles in maternal immune adaptation to pregnancy. While the
effects of EDCs on the immune response to pregnancy are yet to be formally examined, there is substantial evidence from other settings showing that various ECs
can modulate macrophages, T cells, NK cells, and dendritic cells. In particular, EDCs that impair the generation of regulatory T cells (Treg cells), key mediators of
fetal-maternal tolerance that are essential for embryo implantation and placental development, are likely to elevate susceptibility to pregnancy complications, and
warrant investigation as contributing risk factors in recurrent miscarriage, preeclampsia, preterm birth and related gestational disorders.April 2021 | Volume 12 | Article 607539
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immune-modulatory effects of EDCs. Placental macrophages
have been shown to upregulate production of prostaglandin E2
(PGE2) and cyclo-oxygenase-2 after exposure to mono-2-
ethylhexyl phthalate (MEHP), the active metabolite of
diethylhexyl phthalate (DEHP) (125).
Evidence from animal studies indicates that EDCs have
capacity to alter macrophage phenotype and function, in a
manner dependent on the polarization state of the macrophages
at the time of exposure and the specific EDC (110). The most
extensive evidence exists for effects of EDCs in M1-like classical
macrophages. In murine macrophages, treatment with BPA, the
alkyl phenols p-n-nonylphenol (NP) and p-n-octylphenol, or the
chlorinated phenols 2,4-dicholophenol and pentachlorophenol,
each lead to inactivation of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-kB) signaling and suppression
of TNF and nitric oxide (NO) following stimulation with
lipopolysaccharide (LPS) (126–130). Interestingly, the capacity
of BPA to suppress LPS-induced macrophage polarization is
blocked by the ER antagonist ICI 182.780, suggesting BPA acts
to regulate NF-kB signaling via ER (128, 129). Some of these
effects occurred independently of classical ER signaling and were
likely mediated by non-classical ER (129).
Other studies report that BPA and other EDCs have differing
effects on macrophage production of pro-inflammatory
cytokines and mediators, promoting a more activated, classical
M1-like phenotype. For example in the mouse, benzo(a)pyrene
(B(a)P) and hexachlorobenzene increase the production of NO
in macrophage cell lines (127, 131). Similarly, human THP1 cell
line-derived macrophages cultured with BPA exhibit increased
pro-inflammatory TNF and IL-6 expression, dependent on
classical ER signaling (132) Finally, treatment of mouse
macrophages with EDCs including BPA, NP, dicyclohexyl
phthalate and B(a)P causes cell death through apoptosis and
necrosis pathways (127, 131).
Recent studies indicate impacts of various EDCs on M2-like
alternative macrophages. In mice, exposure to polybrominated
diphenyl ethers (PBDE) enhances estrogen mediated regrowth of
mammary glands, in a manner potentially mediated by enhanced
IL-10 expression and polarization of macrophages towards an
M2-like state (133). Similarly, in vivo oral exposure of mice to
BPA promotes the transition from ductal carcinoma in situ to
invasive breast cancer through increases in pro-tumorigenic
cluster of differentiation (CD)206+ M2-like alternatively
activated macrophages (134). In contrast, other studies
demonstrate that in vitro treatment of NP to mouse bone
marrow-derived macrophages decreases their polarization by
IL-4 toward an M2-like phenotype, associated with reduced
survival in LPS-induced sepsis (135).
These studies indicate EDCs at physiological doses may
promote or inhibit several aspects of both classical and
alternate macrophage activation and effector function. The
differential effects observed are likely due to differences in dose,
context and type of EDC, and therefore, further work is required
to develop greater understanding of the effect of EDCs on
macrophages in various settings in mice and humans.Frontiers in Endocrinology | www.frontiersin.org 8Neutrophils
Neutrophils are important in preparing the female reproductive
tract for embryo implantation, especially after coitus when they
clear microorganisms, seminal fluid debris, and superfluous
sperm, and help guard against sexually transmitted infection
(90). Recent studies in mice and humans show that neutrophils
are programmed by decidual signals to acquire an activated, pro-
angiogenic phenotype (136, 137) akin to functions observed for
tumor-associated neutrophils in cancer (138), suggesting a key role
for neutrophils in establishing pregnancy. Given their importance
in protecting from infection, and their emerging roles in regulating
decidualization and placental development, studies to understand
the impact of EDCs on uterine neutrophils may reveal novel
pathways that exert long term influence on offspring health.
In both animal and human models, various EDCs impair
neutrophil chemotactic and phagocytic ability and increase
neutrophil apoptosis (139–142). In humans, chronic exposure to
the pesticide DDT leads to a reduction in neutrophil chemotactic
and phagocytic capacity that inversely correlates with incidence of
infectious disease (143). BPA exposure is associated with increased
reactive oxygen species (ROS) in human neutrophils via ER
signaling, but does not cause changes in ROS-dependent
formation of neutrophil extracellular traps (139).Dendritic Cells
Several effects of EDCs on DC differentiation and maturation are
reported, where EDCs have been shown to shift the polarization
and expression of maturation markers on DCs. In murine
models, in vitro atrazine exposure leads to phenotypic changes,
causing a dose-dependent loss of DC surface MHC class 1, as
well as decreased CD86, CD11b, CD11c and CD14 expression
(144). Other studies show EDCs alter DC cytokine production in
mice, eliciting increased TNF and decreased IL-10 (145, 146). In
other studies, BPA and NP induce the differentiation of murine
bone marrow cells into DCs, with BPA having a more substantial
effect than NP in altering differentiation capacity (147).
Mechanistic studies show that EDCs exert effects on DCs
through both ER-dependent and –independent pathways. In a
model of ovalbumin-induced allergic lung inflammation, NP-
treated mice developed more severe inflammation compared to
the control, however this effect was eliminated in mice carrying
an aryl hydrocarbon receptor (AhR) mutation, suggesting NP
may affect DCs via AhR-dependent (ER independent) pathways
(146). In humans, exposure to the alkylphenols NP enhance TNF
and suppress IL-10 and type 1 IFN production in peripheral
blood mononuclear cell (PBMC)-derived plasmocytoid DCs.
The ER antagonist ICI 182.780 could reverse NP-induced TNF
and IFN-b expression but was unable to reverse the suppressive
effect of NP on IL-10 or IFN-a expression in plasmocytoid DCs,
suggesting both ER-dependent and -independent pathways of
alkyphenol regulation of DCs occur (145).
DCs are critical regulators of the strength and quality of an
adaptive immune response through signals delivered at antigen
presentation, and the impact of EDCs on DC antigen
presentation has been explored. EDCs such as BPA influenceApril 2021 | Volume 12 | Article 607539
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to induce T-helper (Th)2 responses (148). Similarly, suppression
of type 1 IFNs in human plasmocytoid DCs by phthalates
programs a Th2 phenotype in T cells characterized by
suppressed IFN-g and enhanced IL-13 production (149). In
contrast, BPA exposure increases CD1a expression in human
PBMC-derived DCs, enabling them to drive polarization of naïve
CD4+ T cells towards a Th1 phenotype (150). While it is evident
that EDCs can modulate DC phenotype, further studies are
required to understand the specific effects of these DC changes
for T cell phenotype, function, and maturation state.
Effects of EDCs on the DC contribution to pregnancy
tolerance are unclear, but reasonably it would be expected that
altered DC function and interaction with T cells could disrupt
normal immune balance during pregnancy, and potentially skew
permissive Treg cells towards destructive Th1 cells (151). In
particular, an increase in TNF and IL-6 secretion by DCs in the
peri-implantation period may create excessive inflammation that
negatively influences embryo development. Whether EDC-
exposed DCs inhibit Treg cells is an important question with
substantial implications for fetal-maternal tolerance (151).
Natural Killer Cells
Natural killer (NK) cells are affected by a wide range of EDCs, all
of which appear to decrease NK cell recognition of and
cytotoxicity towards tumour cells, even after brief and low
concentration EDC exposure (110). These functions are elicited
through changes in NK cell surface markers and production of
inflammatory cytokines, ultimately leading to changes in cellular
function (110). For example, tributytlin (TBT) and DDT
exposure significantly decrease the cytotoxic function of
human NK cells in vitro, modulating their expression of cell
surface proteins including CD16, CD18 and CD56, as well as
cytolytic proteins such as perforin and granzyme B (152, 153).
The loss of NK cell lytic function following exposure to these
EDCs appears to result from activation of protein kinase C and
the mitogen-activated protein kinase pathway (154–156).
However, not all EDCs elicit the same functional effects in NK
cells. In vitro atrazine exposure inhibits the ability of NK cells to
lyse target cells through blocking lytic granule release, without
impacting the release of perforin or granzyme proteins (157),
demonstrating that EDCs have differing functional effects,
presumably reflecting different mechanisms of action.
EDCs also have significant impact on the production of
inflammatory cytokines by NK cells, with several studies
clearly demonstrating NK cells exhibit non-monotonic dose
responses (110). Inflammatory cytokines such as TNF, IL1-b,
IL-6 and IFN-g were increased in response to low-dose exposure
to various EDCs including TBT and dibutylin (DBT) (158–160).
In the case of TBT-induced pro-inflammatory cytokines this was
mediated through the activation of extracellular-signal-regulated
kinase 1/2 and p38 kinase pathways (158–160).
Overall, these studies demonstrate that EDCs have substantial
capacity to modulate NK cells, in ways relevant to uNK cell
function in pregnancy. uNK cells are highly regulated by ovarian
E2 and P4, and contribute to cyclic remodeling of the uterus over
the course of the menstrual cycle in preparation for embryoFrontiers in Endocrinology | www.frontiersin.org 9implantation (161). Indeed uNK cells are the most abundant
immune cell population in the uterus, where they promote
decidualization, facilitate spiral artery remodeling, and play
critical roles in placental development (99–101). In particular,
the effect of EDCs on NK cells is relevant to the common
condition of endometriosis where exposure to phthalates and
PCBs are implicated, and altered uNK cells are reported (162,
163). To date, there are no studies examining specific changes to
the phenotype or function of the uNK cell subset following
exposure to EDCs, although experiments investigating effects of
BPA on the uterine vasculature point to a possible role for uNK
cells and a target of BPA effects (11, 101). Further research is
required to examine the effect of EDCs on uNK cells and their
role in mediating EDC effects on fertility and fecundity.
CD4+ T Cells
In addition to indirect effects on T cell differentiation through the
impact of EDCs on antigen presenting cells, there is evidence that
EDCs directly influence CD4+ T cell differentiation and function.
In studies of allergic disease, multiple EDCs have been shown to
augment immunoglobulin (Ig)E-related responses through a
common mechanism of enhancing T cell production of the
Th2 inducing cytokine IL-4, via stimulation of nuclear factor
of activated T-cells binding activity (30, 31, 164). Similar
responses are observed in studies comparing adult versus
prenatal exposure to BPA in male mice. In these studies, BPA
promotes the antigen-stimulated production of Th2 cytokines
(IL-10, IL-13 and IL-4) in adult mice, and both IFN-g and IL-4 in
adult offspring exposed to BPA prenatally (165).
In vitro studies of isolated mouse T cells exposed to EDCs
from the alkylphenol family show suppression of Th1
development and enhanced Th2 development, in a manner
independent of retinoic acid receptors, progesterone receptors,
glucocorticoid receptor, retinoid x receptor, or ER (166). While
this Th2 inducing capacity of EDCs is recapitulated in other
studies (167, 168), it is notable that up-regulation of Th1
responses following either adult or prenatal exposure is also
reported. Addition of BPA directly to splenocytes in vitro favours
differentiation of Th1 cells, characterized by decreased IL-4 and
increased IFN-g production (169). The reason for variable effects
of different EDC interventions on CD4+ T cell polarization
remains unclear, but likely reflects the effects of different
chemical entities, dose, duration or in vivo timing of exposure.
Further studies are therefore required to fully understand the
range of impacts of EDCs on CD4+ T cell differentiation.
Taken together, the published findings provide clear evidence
that common EDCs such as BPA and phthalates can modulate T
cell differentiation and function. The disturbance to Th1/Th2
polarization induced by EDCs may predispose to a range of
inflammatory diseases (i.e. allergy, autoimmunity, and asthma)
(110), and is also relevant to generation of maternal immune
tolerance in pregnancy, where a specific suppression of Th1 cells
is critical (34, 35).
As well as affecting Th1/Th2 polarization, BPA exposure
influences the differentiation and functional phenotype of Treg
cells. The elevated antigen-dependent induction of Th2 cytokines
after BPA exposure seen in adult mice occurs in conjunction withApril 2021 | Volume 12 | Article 607539
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decrease in the CD4+CD25+ Treg cells among CD4+ T cells
with increasing BPA concentrations is reported (165). Similarly,
BPA exposure during gestation and prior to weaning leads to a
perturbed induction of oral tolerance characterized by a
diminished accumulation of Treg cells (170). NP exposure in
mice elevates Th2 and suppresses Treg cell numbers, which
counteract the effects of ER agonists in the treatment of
allergic rhinitis (171). In contrast, in vitro exposure of murine
T cells to atrazine inhibits CD4+ T cell proliferation and elicits
increased Foxp3+ Treg cells (172), again highlighting the variable
effects of different EDCs on lymphocyte biology.
A key mechanism implicated in EDCmodulation of Treg cells
involves the transcription factor AhR. In mouse T cells, AhR is a
key regulator of T cell differentiation into Treg and Th17 cells
(173), and AhR activation promotes differentiation of functional
Treg cells (174). EDCs such as dioxins can bind with high affinity
and activate AhR, leading to the induction of functional Treg
cells that suppress experimental autoimmune encephalitis (173).
Activation of AhR by naturally occurring activators of the AhR
signaling pathway, such as 6-formylindolo[3,2-b]carbazole,
elicits an opposite effect where Treg development is suppressed
and Th17 differentiation boosted (173). Since other EDCs
including phenols and phthalates also affect immune processes
via AhR modulation, the AhR pathway may be a central
determinant of the differential impacts of different EDCs on T
cell differentiation (175).
Given these effects, it seems highly plausible that BPA
exposure affects the expansion of Treg cells in early pregnancy
and has potential to compromise fetal-maternal tolerance. Other
EDCs demonstrated to interfere with Treg cell populations could
reasonably also impair maternal immune adaptation to
pregnancy. Given that Treg cell insufficiency is implicated in a
wide range of gestational disorders (35), this warrants
investigation as a convergent mechanism by which EDCs
contribute to elevated susceptibility and the rising incidence of
these conditions.CONCLUSIONS
There is mounting evidence pointing to a contribution of EDCs in
adverse pregnancy outcomes, as well as infertility and subfertility.
While many studies have assessed mechanisms involving
endocrine impacts of EDCs on reproductive processes, there has
been limited exploration of mechanisms involving immune cells.
Given the critical significance of the maternal immune response in
pregnancy and the now substantial literature demonstrating that
common EDCs interfere with key elements of the immune
response relevant to pregnancy (Figure 2), it is important to
consider immune dysregulation amongst the effects that EDCs
may exert. In particular, EDC exposures in women prior to or
around the time of conception have potential to disturb generation
of maternal immune tolerance required at embryo implantation
(34, 35), with ongoing consequences for placental morphogenesis,
and susceptibility to gestational conditions that arise fromFrontiers in Endocrinology | www.frontiersin.org 10compromised placentation. Since seminal fluid factors
contribute to priming immune tolerance towards paternal
antigens in women, is possible that male EDC exposures can
also interfere with maternal immune tolerance in the
female partner.
Research to uncover the significance of immune effects of
EDCs in reproduction and pregnancy is aligned with the World
Health Organization’s recommendation to improve knowledge
on EDCs and human health (1). This research should span a
range of approaches. Laboratory animal studies will be critical for
demonstrating causal effects, elucidating mechanisms, and
defining effects of frequency and strength of different EDC
exposures. Future studies must be designed with a view to
their translational impact for health and clinical relevance. For
example, several studies to date have utilized supraphysiological
doses of EDCs in order to demonstrate an impact, and these now
need to be replicated using environmentally relevant doses (2).
Nevertheless, there is compelling evidence from both
reproduction (2) and immune (22, 110) studies that EDCs can
exert substantial effects at low doses relevant to those in human
environments. Building the evidence for environmentally
relevant exposures is a priority, as is unravelling the complex
biology of the U-shaped dose response curve typical of many
EDCs (2).
Large scale human cohort studies will be important for
investigating how EDCs interact with other environmental and
lifestyle factors that attenuate their biological effects, and
quantifying the relative risk attributable to EDC exposures. As
noted in the US Endocrine Society’s Second Scientific Statement
(2), studies must be carefully designed to take into account
variables that likely attenuate EDC risk, including genetic
diversity, socioeconomic status, geographic variables, age at
exposure, and occupation (3, 42, 43). Importantly, pregnant
women must be included in population studies and future
research must focus on pregnancy as a critical period for
investigation (56). In turn this work will inform public policy
and justify government regulations on environmental exposures
that impact reproductive and pregnancy health. The benefits will
extend to rare and endangered species and economically
important livestock animals, where EDCs will otherwise exert
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